Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment

Ítems similars

• Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment
  per: Uchida, Junji, et al.
  Publicat: (2016)
• Transient appearance of circulating tumor DNA associated with de novo treatment
  per: Kato, Kikuya, et al.
  Publicat: (2016)
• Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients
  per: Kato, Kikuya, et al.
  Publicat: (2016)
• A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation
  per: Imamura, Fumio, et al.
  Publicat: (2016)
• Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data.
  per: Yoji Kukita, et al.
  Publicat: (2013-01-01)